Wednesday, February 12, 2025
HomeMedicineAllergology and ImmunologyVitamin D and Omega-3 Reduce the Risk of Autoimmune Conditions

Vitamin D and Omega-3 Reduce the Risk of Autoimmune Conditions

Taking supplements of vitamin D and omega-3 have been the subject of research studies looking at potential treatments for autoimmune diseases – such as arthritis. However, a recent study investigated the effects of vitamin D and omega-3 supplements on the risk of developing autoimmune diseases – to see if these supplements may be able to prevent the development of these diseases.

The study – called the VITAL trial – was carried out in the United States and included almost 26,000 people. The supplements that were evaluated were prescription grade supplements of 2000IU per day of vitamin D and 1000mg per day of omega-3 fatty acids. The researchers assessed each supplement on its own, as well as a combination of both. The researchers then followed up these participants for five years.

The study reported that people who took vitamin D supplements for five years had a 22% reduction in their chances of having an autoimmune disease. People who took omega-3 supplements had a smaller reduction in their chance of autoimmune disease by 15% – although this number was not statistically significant. 

In fact, the study found that participants in any of the vitamin groups (vitamin D, omega-3, or both) had a lower incidence of confirmed autoimmune disease after five years. 

The researchers suggest that the reduction in the incidence of autoimmune diseases may be because of the anti-inflammatory effects of these vitamins. 

According to the researchers, “The clinical importance of this trial is high because these are well tolerated, non-toxic supplements, and other effective treatments to reduce the incidence of autoimmune diseases are lacking.”

Always speak with your doctor before taking any supplements to make sure they are right for you.

Reference: Hahn J, Cook NR, Alexander EK, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. Published 2022 Jan 26. doi:10.1136/bmj-2021-066452

Image by Leohoho from Pixabay 

Debra Kellen PhD
Debra Kellen PhD
With undergraduate degrees in Neuroscience and Education from the University of Toronto, Debra began her career as a teacher. Nine years later, when she moved to Michigan, Debra earned a Ph.D. in Education Policy from the University of Michigan. Today, Debra organizes conferences and conducts workshops to provide training and support for educators and medical professionals on effective coaching, staff recruitment and training, and creating a culture of continuous improvement. She loves to read and enjoys the challenge of translating medical research into informative, easy-to-read articles. Debra spends her free time with her family, travelling, wandering through art fairs, and canoeing on the Huron River.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

Weight loss drug Tirzepatide helps beat heart failure

New drug, tirzepatide, shows promise for patients with diastolic/preserved ejection fraction heart failure. Find out more with MNB.

Joke Of The Day – February 13

Wife to husband:You know, I feel like more men are interested in me now that I got older. Sara, dear, those men are...

ADVERTISE WITH US

error: Content is read-only and copy-protected.